Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.8600
+0.0100 (1.18%)
At close: Sep 5, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 55.43 million as of September 8, 2025. Its market cap has increased by 45.75% in one year.
Market Cap
55.43M
Enterprise Value
39.10M
Revenue
20.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.86
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 55.43M, a decrease of -76.46%. That is a compound annual growth rate of -30.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 55.43M | 126.63% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 889.85B |
| Atlas Copco AB | 733.43B |
| AB Volvo | 562.84B |
| EQT AB | 389.48B |
| ASSA ABLOY AB | 380.00B |
| Skandinaviska Enskilda Banken AB | 346.65B |
| Sandvik AB | 303.31B |
| Swedbank AB | 298.14B |